MM

Michael Mark

BO BOE: 43 patents #304 of 12,373Top 3%
DG Dr. Karl Thomae Gmbh: 4 patents #59 of 181Top 35%
KG Karl Thomae Gmbh: 2 patents #31 of 87Top 40%
Overall (All Time): #55,651 of 4,157,543Top 2%
49
Patents All Time

Issued Patents All Time

Showing 25 most recent of 49 patents

Patent #TitleCo-InventorsDate
12312352 Use of a DPP-4 inhibitor in SIRS and/or sepsis Thomas KLEIN, Andreas DAIBER, Klaus Dugi, Thomas MUENZEL 2025-05-27
12171767 Uses of DPP IV inhibitors Klaus Dugi, Frank Himmelsbach 2024-12-24
12115179 Pharmaceutical composition, methods for treating and uses thereof Peter Eickelmann, Leo John SEMAN, Leo Thomas, Uli Christian BROEDL, Rolf GREMPLER 2024-10-15
11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug Eva Ulrike GRAEFE-MODY, Thomas KLEIN, Hans-Juergen WOERLE 2024-02-27
11911387 Vasoprotective and cardioprotective antidiabetic therapy Thomas KLEIN, Andreas DAIBER, Odd-Erik JOHANSEN, Sanjaykumar PATEL, Hans-Juergen WOERLE 2024-02-27
11291668 Uses of DPP IV inhibitors Klaus Dugi, Frank Himmelsbach 2022-04-05
10406172 Pharmaceutical composition, methods for treating and uses thereof Peter Eickelmann, Leo John SEMAN, Leo Thomas, Uli Christian BROEDL, Rolf GREMPLER 2019-09-10
10195203 Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome Thomas KLEIN, Maximilian von EYNATTEN 2019-02-05
10092571 Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin Klaus Dugi, Eva Ulrike GRAEFE-MODY, Hans-Juergen WOERLE, Heike ZIMDAHL-GELLING 2018-10-09
10080754 Uses of DPP IV inhibitors Klaus Dugi, Frank Himmelsbach 2018-09-25
10004747 Combination therapy Thomas KLEIN, Rolf GREMPLER 2018-06-26
9713618 Method for modifying food intake and regulating food preference with a DPP-4 inhibitor Thomas KLEIN 2017-07-25
9603851 Combination therapy Thomas KLEIN, Rolf GREMPLER 2017-03-28
9556175 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Roland Maier, Ralf Lotz +1 more 2017-01-31
9526730 Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome Thomas KLEIN, Maximilian von EYNATTEN, Berthold Hocher, Yuliya SHARKOVSKA 2016-12-27
9457029 Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin Klaus Dugi, Eva Ulrike GRAEFE-MODY, Hans-Juergen WOERLE, Heike ZIMDAHL-GELLING 2016-10-04
9321791 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Roland Maier, Ralf Lotz +1 more 2016-04-26
9186392 Combination therapy Thomas KLEIN, Rolf GREMPLER 2015-11-17
9173859 Uses of DPP IV inhibitors Klaus Dugi, Frank Himmelsbach 2015-11-03
9149478 Diabetes therapy Thomas KLEIN, Leo Thomas 2015-10-06
9034883 Vasoprotective and cardioprotective antidiabetic therapy Thomas KLEIN, Andreas DAIBER, Odd-Eric JOHANSEN, Sanjaykumar PATEL, Hans-Juergen WOERLE 2015-05-19
8673927 Uses of DPP-IV inhibitors Klaus Dugi, Frank Himmelsbach 2014-03-18
8664232 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Roland Maier, Ralf Lotz +1 more 2014-03-04
8551957 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate Klaus Dugi, Leo Thomas, Frank Himmelsbach 2013-10-08
8513264 Combination therapy for the treatment of diabetes and related conditions Peter Eickelmann, Gerd LUIPPOLD, Leo Thomas 2013-08-20